High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Bone Marrow Transplantation

• Publication date

  1989-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 2676043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.

  1988cited by this paper
• Regimen-related toxicity in patients undergoing bone marrow transplantation.

  1988cited by this paper
• Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

  1988cited by this paper
• High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.

  1988cited by this paper
• Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

  1987cited by this paper
• High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

  1987cited by this paper
• Results of MIME salvage regimen for recurrent or refractory lymphoma.

  1987cited by this paper
• Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial.

  1987cited by this paper
• Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma.

  1986cited by this paper
• High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma.

  1986cited by this paper
• Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

  1986cited by this paper
• High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma.

  1986cited by this paper
• The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma.

  1985cited by this paper
• Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.

  1985cited by this paper
• High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.

  1985cited by this paper
• The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML.

  1985cited by this paper
• IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.

  1982cited by this paper
• Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation.

  1982cited by this paper
• Bone-marrow transplantation (second of two parts).

  1975cited by this paper
• Bone-marrow transplantation (first of two parts).

  1975cited by this paper
• Technique for human marrow grafting.

  1970cited by this paper

• Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy

  2023cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma

  2015cites this paper
• Methods and biomarkers for outcome prediction after allogeneic hematopoietic stem cell transplantation

  2012cites this paper
• bone marrow transplantation for lymphoid malignancies granulocyte-macrophage colony-stimulating factor after autologous Long-term follow-up of a phase III study of recombinant human

  2011cites this paper
• Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma

  2011cites this paper
• Treatment of a CNS relapse while on therapy for Burkitt lymphoma

  2009cites this paper
• High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma – a retrospective evaluation

  2004cites this paper
• Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

  2003cites this paper
• Autologous and allogeneic transplantation for aggressive NHL.

  2002cites this paper
• Graft versus Burkitt's Lymphoma Effect after Allogeneic Marrow Transplantation

  2002cites this paper
• Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy.

  2002cites this paper
• Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia.

  2001cites this paper
• Allogeneic bone marrow transplantation for lymphoma.

  2000cites this paper
• TRANSPLANTE DE MEDULA ÓSSEA EM PEDIATRIA E TRANSPLANTE DE CORDÃO UMBILICAL

  2000cites this paper
• Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

  2000cites this paper
• Stem‐cell transplant preparative regimens

  1999cites this paper
• Graft-versus-myeloma after withdrawal of immunosuppression following allogeneic peripheral stem cell transplantation

  1999cites this paper
• Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity

  1999cites this paper
• Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation

  1999cites this paper
• Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma.

  1998cites this paper
• Eradication of minimal residual disease during graft‐versus‐host reaction induced by abrupt discontinuation of immunosuppression following bone marrow transplantation in a patient with Ph1‐ALL

  1997cites this paper
• Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

  1997cites this paper
• Bone marrow transplantation for pediatric malignancies.

  1997cites this paper
• Eradication of minimal residual disease during graft-versus-host reaction induced by abrupt discontinuation of immunosuppression following bone marrow transplantation in a patient with Ph1-ALL

  1997cites this paper
• A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

  1997cites this paper
• Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer.

  1996cites this paper
• Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

  1996cites this paper
• Autologous bone marrow transplantation for leukemia and lymphoma.

  1996cites this paper
• Transplantation of bone marrow and peripheral stem cells.

  1996cites this paper
• Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas.

  1995cites this paper
• Autologous bone marrow transplantation.

  1995cites this paper
• Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management.

  1995cites this paper
• High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.

  1995cites this paper
• Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial.

  1995cites this paper
• A u t ol og o us Bo ne Marrow Trans p la n t a t i o n

  1995cites this paper
• Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantation.

  1994cites this paper
• High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.

  1994cites this paper
• Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.

  1993cites this paper
• Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies.

  1993cites this paper
• High‐dose cyclophosphamide, etoposide and BCNU (CVB) with autologous stem cell rescue in malignant lymphomas

  1993cites this paper
• Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation.

  1992cites this paper
• BEAM autografting in lymphoma--experience at one centre.

  1992cites this paper
• Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression.

  1992cites this paper
• Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.

  1992cites this paper
• Non-Hodgkin's lymphoma : biologic classification and implication for therapy

  1991cites this paper
• Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation.

  1991cites this paper
• Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.

  1991cites this paper
• Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.

  1991cites this paper